Boothbay Fund Management’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-301,000
Closed -$4.52M – 1978
2025
Q3
$4.52M Buy
301,000
+197,600
+191% +$2.88M 0.07% 336
2025
Q2
$1.46M Sell
103,400
-6,500
-6% -$116K 0.03% 575
2025
Q1
$2.64M Buy
+109,900
New +$3.88M 0.07% 367
2024
Q2
– Sell
-62,200
Closed -$3.4M – 1533
2024
Q1
$3.4M Buy
+62,200
New +$3.08M 0.07% 335
2023
Q3
– Sell
-45,100
Closed -$1.08M – 1741
2023
Q2
$1.08M Buy
+45,100
New +$776K 0.02% 795

Other funds holding BHVN

Boothbay Fund Management's BHVN Position: Q2 2026 in Review

Boothbay Fund Management increased its Biohaven (BHVN) stake by 80% in Q2 2026, buying an estimated $1.11M and bringing the position to 230,684 shares worth $3.43M. The position accounts for 0.05% of the portfolio, ranked #471.

Boothbay Fund Management first reported a position in BHVN in Q4 2022 and has held it in 7 quarters since. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Boothbay Fund Management held 230,684 shares of Biohaven worth $3.43M as of Q2 2026.
  • Boothbay Fund Management bought 102,822 Biohaven shares in Q2 2026, an estimated $1.11M.
  • Biohaven made up 0.05% of Boothbay Fund Management's portfolio in Q2 2026, its #471 holding.
  • Boothbay Fund Management first reported a position in Biohaven in Q4 2022 and has held it in 7 quarters since.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.